Hosted on Acast. See acast.com/privacy for more information.

This is the fourth episode in our series, Insights Uncovered: A Real-World Data Podcast Series, exploring the evolving landscape of real-world data and its role in shaping healthcare decisions.

The episode will take a closer look at healthcare access in the United States – a topic that continues to dominate conversations in political, public health, and economic circles. While much of the national dialogue centers on insurance coverage and affordability, the reality is that access to care involves far more than simply having insurance.

Also covered in the episode are the policies, data, and real-world factors that influence healthcare access for the 92% of Americans who are insured.

Guests are:

- Liisa Palmer, Portfolio Leader for Real World Data Research & Analytics at MarketScan

- And Katherine Shanahan, Senior Pharmacy Analytic Advisor for Health Insights, Truven’s healthcare analytics platform for payers and employers

Hosted on Acast. See acast.com/privacy for more information.

Join us for the latest installment of Novotech’s expert podcast, exploring the rapidly evolving world of global obesity clinical trials and the transformative role of GLP-1 therapies.

Dr. Stecco is a healthcare executive with 25 years of leadership and medical monitoring experience across the pharmaceutical, biotech, and medical device sectors. A former Chief Medical Officer and consultant to over20 obesity-focused companies, she is also a practicing physician with deep expertise in treating obesity using therapies like GLP-1 receptor agonists, Orlistat, Qsymia, and Contrave. Dr.Stecco holds an MA and MD from the University of Southern California and completed her surgical training at Stanford University Medical Center.

Gab is a seasoned clinical research professional with over 20 years of experience across both site and CRO settings. He has held key roles including Senior Study Coordinator, CRA, Project Manager, and Therapeutic Strategy Manager. Gab has significant expertise in Phase I–III clinical trials conducted in Australia and globally, with a strong focus on early-phase research — covering study design, protocol development, regulatory strategy, feasibility, budgeting, and timeline management. He currently leads the Strategy team for the obesity portfolio. Gab holds a Bachelor of Nursing and a Master of Health Sciences in Health Administration.​

Hosted on Acast. See acast.com/privacy for more information.

Supply chains for critical minerals are very complex, but several markets are making advances in traceability and provenance such as IRMA certification, ISO standards, EU Battery Passport. Queensland in Australia is taking learnings to inform its own traceability framework for critical minerals.

The second episode on critical minerals in Queensland gains insights into a supply chain report titled A Vision and Roadmap for Critical Minerals Provenance and Traceability, produced by FrontierSI in partnership with the Department of Natural Resources in Queensland. FrontierSI is a social enterprise that applies its expertise in location analytics to address environmental and industrial challenges. We learn more about the research, with guests:

- Gavin Kennedy, interim spatial sector lead at FrontierSI

- Jia-Urnn Lee, strategic growth lead at FrontierSI

Hosted on Acast. See acast.com/privacy for more information.

This episode explores the world of nitinol – a material that’s revolutionising medical device design. The episode learns more about the super-elasticity properties of nitinol, which can undergo significant deformation and still return to its original shape. These properties make nitinol an optimum material for stents and guidewires in cardiovascular care. Also discussed are how nitinol fits into the trend of smaller and smarter medical devices.

Guests of the fifth episode of the Advancing the Future of MedTech with Alleima podcast series are:

- Bernd Vogel, global technology and innovation manager at Alleima’s Medical unit

- Steffen Müller, sales and marketing director at Alleima’s Medical unit

Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See acast.com/privacy for more information.

Critical minerals are essential for future technologies such as electric vehicles, semiconductors, and renewable energy installations. Australia, and especially Queensland, has abundant critical mineral deposits to meet this demand.

In this episode, we explore what Queensland has to offer in this vital industry. The first guest is Namali Mackay, managing director of Critical Minerals Association Australia.

The level of progress in critical minerals in Queensland would not be possible without the support of the state government.

The second guest is Paul Holden, the lead of Critical Minerals Queensland, a newly created office by the Queensland Government focused on advancing the potential of the state’s critical minerals sector.

Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See acast.com/privacy for more information.

This finale in the first Zelta Podcast series follows up on an article published on 8 January on Pharmaceutical-Technology.com and ClinicalTrialsArena.com, titled ‘Clinical trial trends in 2025: Investment headwinds, wearables, and targeted AI uses’.

The article examined the financial challenges facing clinical trials, which have created a more risk-averse landscape. It explored the digital solutions that could be key for sponsors and CROs to optimize budgets and resources, as well as the trends to watch out for in 2025.

The interviewee for that article was Jennifer Duff, Executive Vice President and General Manager of Zelta by Merative Clinical Trials Solutions. Jennifer is the guest for this episode, where we revisit the original predictions to see how accurate they were and if there were any surprises. 

Hosted on Acast. See acast.com/privacy for more information.

This podcast examines how real-world data (RWD) helps fill gaps in understanding maternal and infant health, particularly since pregnant individuals are often excluded from clinical trials.

The latest episode in the Insights Uncovered: Real-World Data Podcast Series speaks with experts at MarketScan to learn how RWD enables linking mother-infant records to aspects such as study outcomes, assessing medication safety, evaluating healthcare services, and monitoring pregnancy risk factors and public health policies.

The guests from MarketScan are:

• Elizabeth Packnett, MPH, Lead Researcher, Real World Data Research & Analytics
• Luke Boulanger, Director, Technology Product Management
• Liisa Palmer, PhD, Portfolio Leader, Real World Data Research & Analytics

Hosted on Acast. See acast.com/privacy for more information.